Covered recipient · General Payments record
AMY M MOSCHELL
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,848.87
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.70 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $93.84 | 4 |
| Oyster Point Pharma, Inc. | $86.19 | 4 |
| ABBVIE INC. | $75.85 | 3 |
| Amgen Inc. | $55.23 | 3 |
| Harrow Eye, LLC | $26.65 | 1 |
| Alcon Laboratories Inc | $14.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.93 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071147 | CMS |
| ABBVIE INC. | $22.88 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071149 | CMS |
| ABBVIE INC. | $23.04 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071151 | CMS |
| Alcon Vision LLC | $14.94 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563249 | CMS |
| Amgen Inc. | $16.83 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656483 | CMS |
| Amgen Inc. | $18.63 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656485 | CMS |
| Amgen Inc. | $19.77 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656487 | CMS |
| Harrow Eye, LLC | $26.65 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145610307 | CMS |
| Oyster Point Pharma, Inc. | $14.68 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147403376 | CMS |
| Oyster Point Pharma, Inc. | $22.09 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147405230 | CMS |
| Oyster Point Pharma, Inc. | $23.56 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147409823 | CMS |
| Oyster Point Pharma, Inc. | $25.86 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147411655 | CMS |
| Tarsus Pharmaceuticals, Inc. | $19.92 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139118756 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.40 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139118758 | CMS |
| Tarsus Pharmaceuticals, Inc. | $24.56 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139118760 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.96 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139118762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.